Skip to main content
Premium Trial:

Request an Annual Quote

MDS Reports 5-Percent Organic Growth in Analytics Revenue

NEW YORK (GenomeWeb News) — MDS today reported that second-quarter revenue for its MDS Analytical Technologies segment, which now includes MDS Sciex and Molecular Devices, increased 54 percent, although organic growth was 5 percent.
Total revenue for the three months ended March 31 increased to $88 million from $57 million. The majority of the increase came from recently acquired Molecular Devices, which MDS bought in March for $615 million. The company also recorded $3 million in expenses from the acquisition.  
R&D spending increased to $7 million from $1 million year over year.  
MDS said its services revenue drove growth and profitability.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.